Nov 9, 2015
Lytix Biopharma presented LTX-315 at melanoma conference in Rome

Andrew Saunders (CMO of Lytix Biopharma) presented LTX-315 at THIRD MELANOMA MIB CONFERENCE in Rome November 9th.

See program